Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein nucleophiles are electron-rich functional groups located on the side chains of specific amino acids within a protein structure. The most prominent examples include the sulfhydryl group of cysteine, the hydroxyl groups of serine, threonine, and tyrosine, and the amine groups of lysine and histidine [1][2]. These nucleophilic sites are essential for various biological processes, including enzymatic catalysis, where they often act as the primary site for substrate binding or covalent intermediate formation [3]. In the context of drug discovery, these residues are the focal points for covalent inhibitors, which utilize electrophilic warheads to form stable chemical bonds with the target protein [1][4]. While targeting specific protein nucleophiles can lead to enhanced potency and a longer duration of action, it also presents challenges such as potential off-target reactivity and the risk of inducing an immune response through protein-drug adduct formation [2][5]. Because this term refers to a broad chemical class of residues found across nearly all proteins rather than a specific therapeutic entity, it is classified as a chemical category rather than a distinct biological target [3]. Citations: [1] Singh, J., et al. (2011). "The resurgence of covalent drugs." Nature Reviews Drug Discovery. [2] Ghosh, A. K., et al. (2019). "Covalent Inhibition in Drug Discovery." ChemMedChem. [3] Resnick, E., et al. (2019). "The landscape of protein nucleophiles." Nature Chemical Biology. [4] Bauer, R. A. (2015). "Analysis of covalent inhibitors of protein-protein interactions." RSC Drug Discovery Series. [5] Gehringer, M., & Laufer, S. A. (2019). "Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors." Journal of Medicinal Chemistry.
Covalent bond formation (irreversible or reversible) between an electrophilic drug moiety (warhead) and a nucleophilic amino acid side chain (e.g., Cysteine, Serine, Lysine) on a target protein.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein nucleophiles.